Group One Trading, L.P. Novo Nordisk A S Transaction History

Group One Trading, L.P.

$3.01 Billion
Q2 2024

A detailed history of Group One Trading, L.P. transactions in Novo Nordisk A S stock. As of the latest transaction made, Group One Trading, L.P. holds 88,918 shares of NVO stock, worth $9.57 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

88,918

Previous 88,325 0.67%

Holding current value

$9.57 Million

Previous $11.3 Million 11.92%

% of portfolio

0.42%

Previous 0.42%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $72,767 - $87,117	593 Added 0.67%	88,918 $12.7 Million
Q1 2024 May 10, 2024	SELL	$102.11 - $135.92 $9.68 Million - $12.9 Million	-94,784 Reduced 51.76%	88,325 $11.3 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $9.92 Million - $11.9 Million	112,999 Added 161.17%	183,109 $18.9 Million
Q3 2023 Nov 09, 2023	BUY	$90.94 - $199.54 $4.46 Million - $9.78 Million	49,030 Added 232.59%	70,110 $6.38 Million
Q2 2023 Aug 09, 2023	BUY	$155.98 - $172.65 $1.84 Million - $2.03 Million	11,776 Added 126.57%	21,080 $3.41 Million
Q1 2023 May 12, 2023	BUY	$132.34 - $159.14 $1.23 Million - $1.48 Million	9,304 New	9,304 $1.48 Million
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $1.91 Million - $2.33 Million	-19,925 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $1.99 Million - $2.52 Million	-23,593 Reduced 54.21%	19,925 $1.91 Million
Q2 2021 Aug 10, 2021	SELL	$67.66 - $84.76 $216,512 - $271,232	-3,200 Reduced 6.85%	43,518 $3.65 Million
Q1 2021 May 12, 2021	BUY	$67.06 - $75.82 $2.72 Million - $3.08 Million	40,580 Added 661.13%	46,718 $3.15 Million
Q4 2020 Feb 10, 2021	BUY	$63.89 - $73.8 $68,042 - $78,597	1,065 Added 20.99%	6,138 $429,000
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $1.06 Million - $1.17 Million	-16,611 Reduced 76.6%	5,073 $352,000
Q2 2020 Aug 13, 2020	BUY	$58.54 - $67.94 $1.17 Million - $1.36 Million	19,948 Added 1149.08%	21,684 $1.42 Million
Q1 2020 May 13, 2020	SELL	$49.46 - $64.78 $420,954 - $551,342	-8,511 Reduced 83.06%	1,736 $105,000
Q4 2019 Feb 10, 2020	BUY	$49.86 - $58.26 $510,915 - $596,990	10,247 New	10,247 $593,000
Q2 2019 Aug 09, 2019	SELL	$46.79 - $52.47 $163,531 - $183,382	-3,495 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$46.36 - $52.63 $162,028 - $183,941	3,495 New	3,495 $183,000
Q3 2018 Nov 08, 2018	SELL	$46.76 - $51.24 $272,610 - $298,729	-5,830 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $258,210 - $293,948	5,830 New	5,830 $269,000
Q3 2017 Nov 15, 2017	SELL	$41.15 - $49.22 $49,421 - $59,113	-1,201 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	1,201	1,201 $52,000

Others Institutions Holding NVO

# of Institutions

1,953

Shares Held

321M

Call Options Held

5.16M

Put Options Held

4.96M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $243B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Novo Nordisk A S Transaction History